8 research outputs found
A helminth-derived suppressor of ST2 blocks allergic responses.
The IL-33-ST2 pathway is an important initiator of type 2 immune responses. We previously characterised the HpARI protein secreted by the model intestinal nematode Heligmosomoides polygyrus, which binds and blocks IL-33. Here, we identify H. polygyrus Binds Alarmin Receptor and Inhibits (HpBARI) and HpBARI_Hom2, both of which consist of complement control protein (CCP) domains, similarly to the immunomodulatory HpARI and Hp-TGM proteins. HpBARI binds murine ST2, inhibiting cell surface detection of ST2, preventing IL-33-ST2 interactions, and inhibiting IL-33 responses in vitro and in an in vivo mouse model of asthma. In H. polygyrus infection, ST2 detection is abrogated in the peritoneal cavity and lung, consistent with systemic effects of HpBARI. HpBARI_Hom2 also binds human ST2 with high affinity, and effectively blocks human PBMC responses to IL-33. Thus, we show that H. polygyrus blocks the IL-33 pathway via both HpARI which blocks the cytokine, and also HpBARI which blocks the receptor
IruO Uses an FAD Semiquinone Intermediate for Iron-Siderophore Reduction
Many pathogenic bacteria including Staphylococcus aureus use iron-chelating siderophores to
acquire iron. IruO, an FAD-containing NADPH-dependent reductase from S. aureus, functions
as a reductase for IsdG and IsdI, two paralogous heme degrading enzymes. Also, the gene
encoding for IruO was shown to be required for growth of S. aureus on hydroxamate
siderophores as a sole iron source. Here, we show that IruO binds the hydroxamate-type
siderophores desferrioxamine B and ferrichrome A with low micromolar affinity and in the
presence of NADPH, Fe(II) was released. Steady-state kinetics of Fe(II) release provides kcat/Km
values in the range of 600 to 7000 M-Ā¹s-Ā¹ for these siderophores supporting a role for IruO as a
siderophore reductase in iron utilization. Crystal structures of IruO were solved in two distinct
conformational states mediated by the formation of an intramolecular disulfide bond. A putative
siderophore binding site was identified adjacent to the FAD cofactor. This site is partly occluded
in the oxidized IruO structure consistent with this form being less active than reduced IruO. This
reduction in activity could have a physiological role to limit iron release under oxidative stress
conditions. Visible spectroscopy of anaerobically reduced IruO showed that the reaction
proceeds by a single electron transfer mechanism through an FAD semiquinone intermediate.
From the data a model for single electron siderophore reduction by IruO using NADPH is
described.Science, Faculty ofMicrobiology and Immunology, Department ofReviewedFacultyPostdoctora
Iron Uptake Oxidoreductase (IruO) Uses a Flavin Adenine Dinucleotide Semiquinone Intermediate for Iron-Siderophore Reduction
Many pathogenic bacteria
including <i>Staphylococcus aureus</i> use iron-chelating
siderophores to acquire iron. Iron uptake oxidoreductase
(IruO), a flavin adenine dinucleotide (FAD)-containing nicotinamide
adenine dinucleotide phosphate (NADPH)-dependent reductase from <i>S. aureus</i>, functions as a reductase for IsdG and IsdI, two
paralogous heme degrading enzymes. Also, the gene encoding for IruO
was shown to be required for growth of S. <i>aureus</i> on
hydroxamate siderophores as a sole iron source. Here, we show that
IruO binds the hydroxamate-type siderophores desferrioxamine B and
ferrichrome A with low micromolar affinity and in the presence of
NADPH, FeĀ(II) was released. Steady-state kinetics of FeĀ(II) release
provides <i>k</i><sub>cat</sub>/<i>K</i><sub>m</sub> values in the range of 600 to 7000 M<sup>ā1</sup> s<sup>ā1</sup> for these siderophores supporting a role for IruO as a siderophore
reductase in iron utilization. Crystal structures of IruO were solved
in two distinct conformational states mediated by the formation of
an intramolecular disulfide bond. A putative siderophore binding site
was identified adjacent to the FAD cofactor. This site is partly occluded
in the oxidized IruO structure consistent with this form being less
active than reduced IruO. This reduction in activity could have a
physiological role to limit iron release under oxidative stress conditions.
Visible spectroscopy of anaerobically reduced IruO showed that the
reaction proceeds by a single electron transfer mechanism through
an FAD semiquinone intermediate. From the data, a model for single
electron siderophore reduction by IruO using NADPH is described
Functional specialization of intestinal dendritic cell subsets during Th2 helminth infection in mice
Dendritic cells (DCs) are essential in dictating the nature and effectiveness of immune responses. In the intestine DCs can be separated into discrete subsets, defined by expression of CD11b and CD103, each with different developmental requirements and distinct functional potential. Recent evidence has shown that different intestinal DC subsets are involved in the induction of T helper (Th)17 and regulatory T cell responses, but the cells that initiate Th2 immune responses are still incompletely understood. We show that in the Th2 response to an intestinal helminth in mice, only CD11b+ and not CD11bā DCs accumulate in the local lymph node, upregulate PDL2 and express markers of alternative activation. An enteric Th1 response instead activated both CD11b+ and CD11bā DCs without eliciting alternative activation in either population. Functionally, only CD11b+ DCs activated during helminth infection supported Th2 differentiation in naive CD4+ T cells. Together our data demonstrate that the ability to prime Th2 cells during intestinal helminth infection, is a selective and inducible characteristic of CD11b+ DCs
Metabolic heterogeneity of tissue-resident macrophages in homeostasis and during helminth infection
Abstract Tissue-resident macrophage populations constitute a mosaic of phenotypes, yet how their metabolic states link to the range of phenotypes and functions in vivo is still poorly defined. Here, using high-dimensional spectral flow cytometry, we observe distinct metabolic profiles between different organs and functionally link acetyl CoA carboxylase activity to efferocytotic capacity. Additionally, differences in metabolism are evident within populations from a specific site, corresponding to relative stages of macrophage maturity. Immune perturbation with intestinal helminth infection increases alternative activation and metabolic rewiring of monocyte-derived macrophage populations, while resident TIM4+ intestinal macrophages remain immunologically and metabolically hyporesponsive. Similar metabolic signatures in alternatively-activated macrophages are seen from different tissues using additional helminth models, but to different magnitudes, indicating further tissue-specific contributions to metabolic states. Thus, our high-dimensional, flow-based metabolic analyses indicates complex metabolic heterogeneity and dynamics of tissue-resident macrophage populations at homeostasis and during helminth infection
Tissue-based IL-10 signalling in helminth infection limits IFNĪ³ expression and promotes the intestinal Th2 response
Type 2 immunity is activated in response to both allergens and helminth infection. It can be detrimental or beneficial, and there is a pressing need to better understand its regulation. The immunosuppressive cytokine IL-10 is known as a T helper 2 (Th2) effector molecule, but it is currently unclear whether IL-10 dampens or promotes Th2 differentiation during infection. Here we show that helminth infection in mice elicits IL-10 expression in both the intestinal lamina propria and the draining mesenteric lymph node, with higher expression in the infected tissue. In vitro, exogenous IL-10 enhanced Th2 differentiation in isolated CD4+ T cells, increasing expression of GATA3 and production of IL-5 and IL-13. The ability of IL-10 to amplify the Th2 response coincided with its suppression of IFNĪ³ expression and in vivo we found that, in intestinal helminth infection, IL-10 receptor expression was higher on Th1 cells in the small intestine than on Th2 cells in the same tissue, or on any Th cell in the draining lymph node. In vivo blockade of IL-10 signalling during helminth infection resulted in an expansion of IFNĪ³+ and Tbet+ Th1 cells in the small intestine and a coincident decrease in IL-13, IL-5 and GATA3 expression by intestinal T cells. These changes in Th2 cytokines correlated with reduced expression of type 2 effector molecules, such as RELMĪ±, and increased parasite egg production. Together our data indicate that IL-10 signalling promotes Th2 differentiation during helminth infection at least in part by regulating competing Th1 cells in the infected tissue
Spatial regulation of IL-4 signalling in vivo
Type 2 immune responses are defined by the cytokines interleukin 4 (IL-4), IL-5 and IL-13 and the cellular and physiological changes that these cytokines induce, including IgE production, eosinophilia, mast cell degranulation, mucus secretion and smooth muscle contraction. Together these responses provide a āweep and sweepā reflex that is optimised to expel parasitic worms. The same response can also be pathological when mis-timed or activated inappropriately. Current understanding of the orchestration and regulation of type 2 immunity is rapidly advancing, with recent identification of participating innate cells and elucidation of the cytokine signals responsible for their activation. In vivo, the outcome of cytokine signalling is critically dependent on timing, location and context. In this commentary, we describe the spatiotemporal control of type 2 cytokine signalling, consider its implications for bystander cells, and discuss its significance during co-infection